Nonimmune hydrops fetalis and fulminant fatal disease due to congenital cytomegalovirus infection in a premature infant

Journal of Perinatology

Volumn 25, Issue 9, 2005, Pages 608-611

  Sampath, Venkatesh ^a   Narendan, Vivek ^a   Donovan, Edward F ^a   Stanek, Jerzy ^b,c   Schleiss, Mark R ^b,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BICARBONATE; GANCICLOVIR;

ARTICLE; AUTOPSY; BIRTH WEIGHT; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; ENTERITIS; FATALITY; FETUS HYDROPS; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INFANT DISEASE; MALE; MYOCARDITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NONHUMAN; PNEUMONIA; PREMATURITY;

CYTOMEGALOVIRUS INFECTIONS; FATAL OUTCOME; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MALE;

EID: 31044432973     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211357     Document Type: Article

References (26)

1. Lallemand AV, Doco-Fenzy M, Gaillard DA. Investigation of nonimmune hydrops fetalis: Multidisciplinary studies are necessary for diagnosis - review of 94 cases. Pediatr Dev Pathol 1999;2(5):432-9.
2. Barron SD, Pass RF. Infectious causes of hydrops fetalis. Semin Perinatol 1995;19(6):493-501.
3. Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004;24(7):513-8.
4. Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: Recent advances in antiviral therapy. Expert Rev Anti Infect Ther 2004;2(3):389-403.
5. O'Malley A, Barry-Kinsella C, Hughes C, et al. Parvovirus infects cardiac myocytes in hydrops fetalis. Pediatr Dev Pathol 2003;6(5):414-20.
6. Dehtiar N, Eherlichman M, Picard E, et al. Cytomegalovirus myocarditis in a healthy infant: Complete recovery after ganciclovir treatment. Pediatr Crit Care Med 2001;2(3):271-3.
7. Bissinger AL, Sinzger C, Kaiserling E, Jahn G. Human cytomegalovirus as a direct pathogen: Correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol 2002;67(2):200-6.
8. Beksac MS, Saygan-Karamursel B, Ustacelebi S, et al. Prenatal diagnosis of intrauterine cytomegalovirus infection in a fetus with non-immune hydrops fetalis. Acta Obstet Gynecol Scand 2001;80(8):762-5.
9. Mazeron MC, Cordovi-Voulgaropoulos L, Perol Y. Transient hydrops fetalis associated with intrauterine cytomegalovirus infection: Prenatal diagnosis. Obstet Gynecol 1994;84(4, Part 2):692-4.
10. Inoue T, Matsumura N, Fukuoka M, Sagawa N, Fujii S. Severe congenital cytomegalovirus infection with fetal hydrops in a cytomegalovirus-seropositive healthy woman. Eur J Obstet Gynecol Reprod Biol 2001;95(2): 184-6.
11. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt AJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344(18):1366-71.
12. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 1999;31(5):443-57.
13. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002;15:680-715.
14. Schleiss MR, Bernstein DI, McVoy MA, et al. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs. Antiviral Res 2005;65(1):35-43.
15. Kimberlin DW, Lin CY, Sanchez PJ, et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial. J Pediatr 2003;143(1):16-25.
16. Hocker J, Cook LN, Adams G, Rabalais G. Ganciclovir therapy of congenital cytomegalovirus pneumonia. Pediatr Infect Dis J 1990;9:743-5.
17. Attard-Montalto SP, English MC, Stimmler L, Snodgrass GJ. Ganciclovir treatment of congenital cytomegalovirus infection: A report of two cases. Scand J Infect Dis 1993;25(3):385-8.
18. Stronati M, Revello MG, Cerbo RM, Furione M, Rondini G, Gerna G. Ganciclovir therapy of congenital human cytomegalovirus hepatitis. Acta Paediatr 1995;84(3):340-1.
19. Vallejo JG, Englund JA, Garcia-Prats JA, Demmler GJ. Ganciclovir treatment of steroid-associated cytomegalovirus disease in a congenitally infected neonate. Pediatr Infect Dis J 1994;13(3):239-41.
20. Michaels MG, Greenberg DP, Sabo DL, Wald ER. Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis J 2003;22(6):504-9.
21. Nigro G, Scholz H, Bartmann U. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: A two-regimen experience. J Pediatr 1994;124(2):318-22.
22. Crowley B. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection. J Antimicrob Chemother 2002;50(3):435-6.
23. Fischler B, Casswall TH, Malmborg P, Nemeth A. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr 2002;34(2):154-7.
24. Griffiths PD, Walter S. Cytomegalovirus. Curr Opin Infect Dis 2005;18(3):241-5.
25. Plotkin SA. Vaccination against cytomegalovirus, the changeling demon. Pediatr Infect Dis J 1999;18:313-25.
26. Schleiss MR, Heineman TC. Progress toward an elusive goal: Current status of cytomegalovirus (CMV) vaccines. Expert Rev Vaccines 2005;4(3):381-406.